Israel Englander Harrow Health, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Harrow Health, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 67,262 shares of HROW stock, worth $1.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

67,262

Previous 168,933 60.18%

Holding current value

$1.89 Million

Previous $7.6 Million 70.3%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$33.39 - $57.5 $3.39 Million - $5.85 Million	-101,671 Reduced 60.18%	67,262 $2.26 Million
Q3 2024 Nov 14, 2024	BUY	$20.85 - $46.47 $642,096 - $1.43 Million	30,796 Added 22.29%	168,933 $7.6 Million
Q2 2024 Aug 14, 2024	SELL	$10.0 - $21.64 $209,410 - $453,163	-20,941 Reduced 13.16%	138,137 $2.89 Million
Q1 2024 May 15, 2024	BUY	$9.3 - $13.23 $170,208 - $242,135	18,302 Added 13.0%	159,078 $2.1 Million
Q4 2023 Feb 14, 2024	BUY	$8.1 - $16.36 $1.14 Million - $2.3 Million	140,776 New	140,776 $1.58 Million
Q1 2023 May 15, 2023	BUY	$13.84 - $21.46 $1.27 Million - $1.96 Million	91,564 Added 60.44%	243,067 $5.14 Million
Q4 2022 Feb 14, 2023	BUY	$10.28 - $14.78 $531,362 - $763,963	51,689 Added 51.79%	151,503 $2.24 Million
Q3 2022 Nov 14, 2022	SELL	$6.57 - $24.88 $673,963 - $2.55 Million	-102,582 Reduced 50.68%	99,814 $1.21 Million
Q2 2022 Aug 15, 2022	BUY	$5.75 - $7.74 $24,477 - $32,949	4,257 Added 2.15%	202,396 $1.47 Million
Q1 2022 May 16, 2022	SELL	$6.77 - $8.66 $52,711 - $67,426	-7,786 Reduced 3.78%	198,139 $1.35 Million
Q4 2021 Feb 14, 2022	SELL	$8.5 - $12.0 $320,110 - $451,920	-37,660 Reduced 15.46%	205,925 $1.78 Million
Q3 2021 Nov 15, 2021	SELL	$6.99 - $10.6 $917,199 - $1.39 Million	-131,216 Reduced 35.01%	243,585 $2.21 Million
Q2 2021 Aug 16, 2021	BUY	$6.68 - $11.07 $2.29 Million - $3.8 Million	343,111 Added 1082.71%	374,801 $3.48 Million
Q1 2021 May 17, 2021	SELL	$6.26 - $11.03 $476,085 - $838,853	-76,052 Reduced 70.59%	31,690 $214,000
Q4 2020 Feb 16, 2021	BUY	$4.76 - $6.93 $512,851 - $746,652	107,742 New	107,742 $739,000
Q2 2020 Aug 14, 2020	SELL	$3.61 - $6.47 $954,368 - $1.71 Million	-264,368 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$3.5 - $7.31 $925,288 - $1.93 Million	264,368 New	264,368 $1.01 Million
Q3 2019 Nov 14, 2019	SELL	$4.89 - $8.0 $129,873 - $212,472	-26,559 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$4.2 - $8.7 $59,409 - $123,061	14,145 Added 113.94%	26,559 $231,000
Q2 2019 Aug 14, 2019	SELL	$4.2 - $8.7 $848,097 - $1.76 Million	-201,928 Reduced 94.21%	12,414 $1.06 Million
Q1 2019 May 14, 2019	BUY	$4.75 - $7.1 $1.02 Million - $1.52 Million	214,342 New	214,342 $1.07 Million

Others Institutions Holding HROW

# of Institutions

185

Shares Held

21.1M

Call Options Held

679K

Put Options Held

1.27M

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $760M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account